Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 Trial

How Soap Works: The Science Behind Handwashing

Former CEO and director of Reuters is large investor and board member of Pfizer

Pfizer update: Three doses advised for omicron variant based on initial studies.

Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%

mRNA vaccine trial for Lyme disease

Pfizer submits Covid vaccine to FDA for approval, to distribute in December

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study that is 90% Effictive